Aviva Systems Biology Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Private

  • Employees
  • 30

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 1

Aviva Systems Biology General Information

Description

Developer of antibodies intended to be used for research and diagnostic applications. The company's produced antibodies can adapt to the physical, chemical, and biological properties of cells to perform complex analysis in areas of transcription, epigenetics, and cell signaling, enabling researchers and scientists to study the transcription factors, cancer, cardiovascular, and cell biology for improved treatment methods.

Contact Information

Formerly Known As
AVIVA Biosciences
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 10211 Pacific Mesa Boulevard
  • Suite 401
  • San Diego, CA 92121
  • United States
+1 (858)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 10211 Pacific Mesa Boulevard
  • Suite 401
  • San Diego, CA 92121
  • United States
+1 (858)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aviva Systems Biology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 01-Sep-2021 Completed Generating Revenue
2. Later Stage VC 25-Sep-2002 Completed Generating Revenue
1. Early Stage VC 12-Jun-2002 $5M $5M Completed Generating Revenue
To view Aviva Systems Biology’s complete valuation and funding history, request access »

Aviva Systems Biology Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of antibodies intended to be used for research and diagnostic applications. The company's produced antibodies
Biotechnology
San Diego, CA
30 As of 2021

Cranbury, NJ
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aviva Systems Biology Competitors (63)

One of Aviva Systems Biology’s 63 competitors is PeproTech, a Corporate Backed or Acquired company based in Cranbury, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
PeproTech Corporate Backed or Acquired Cranbury, NJ
BioLegend Formerly Accelerator/Incubator backed San Diego, CA
PlantForm Venture Capital-Backed Toronto, Canada
NexImmune Formerly VC-backed Gaithersburg, MD
ProMab Biotechnologies Corporate Backed or Acquired Richmond, CA
You’re viewing 5 of 63 competitors. Get the full list »

Aviva Systems Biology Patents

Aviva Systems Biology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3242929-A1 Methods and devices for breaking cell aggregation and separating or enriching cells Inactive 09-Jan-2015
CA-2973388-A1 Methods and devices for breaking cell aggregation and separating or enriching cells Inactive 09-Jan-2015
AU-2016205090-A1 Methods and devices for breaking cell aggregation and separating or enriching cells Inactive 09-Jan-2015
US-20160237397-A1 Methods and devices for breaking cell aggregation and separating or enriching cells Inactive 09-Jan-2015
EP-3242929-A4 Methods and devices for breaking cell aggregation and separating or enriching cells Inactive 09-Jan-2015 C12M47/04
To view Aviva Systems Biology’s complete patent history, request access »

Aviva Systems Biology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aviva Systems Biology Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Axon Instruments Corporation Minority
To view Aviva Systems Biology’s complete investors history, request access »

Aviva Systems Biology Acquisitions (1)

Aviva Systems Biology’s most recent deal was a Merger/Acquisition with GenWay BioTech. The deal was made on 23-Feb-2017.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
GenWay BioTech 23-Feb-2017 Merger/Acquisition Discovery Tools (Healthcare)
To view Aviva Systems Biology’s complete acquisitions history, request access »

Aviva Systems Biology FAQs

  • When was Aviva Systems Biology founded?

    Aviva Systems Biology was founded in 1997.

  • Where is Aviva Systems Biology headquartered?

    Aviva Systems Biology is headquartered in San Diego, CA.

  • What is the size of Aviva Systems Biology?

    Aviva Systems Biology has 30 total employees.

  • What industry is Aviva Systems Biology in?

    Aviva Systems Biology’s primary industry is Biotechnology.

  • Is Aviva Systems Biology a private or public company?

    Aviva Systems Biology is a Private company.

  • What is Aviva Systems Biology’s current revenue?

    The current revenue for Aviva Systems Biology is .

  • How much funding has Aviva Systems Biology raised over time?

    Aviva Systems Biology has raised $16.8M.

  • Who are Aviva Systems Biology’s investors?

    Axon Instruments has invested in Aviva Systems Biology.

  • Who are Aviva Systems Biology’s competitors?

    PeproTech, BioLegend, PlantForm, NexImmune, and ProMab Biotechnologies are some of the 63 competitors of Aviva Systems Biology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »